$7.25
-1.73-19.27%
Last update: Sep 6, 7:41 AM
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Avalo Therapeutics in recent months.
Browse guidance and forecast on all stocks.